: Determination of non-lethal BMS345541 mono-treatment dose for EMDR of pre-B ALL cells in the presence of stroma. A. Western blot analysis with the indicated antibodies on 20 μg total cell lysates of US7 or TXL2 cells treated for 24 hours with 0, 5 and 10 μM BMS345541. B. Cell counts and viability of TXL2 cells grown on OP9 stroma and treated for 72 hours with the indicated drugs (*p < 0.05, **p < 0.001). C. Long-term viability and cell counts of US7 cells over a 28-day period when treated with solvent, or the indicated drugs. Fresh drugs were added with every medium change. (D, E) Cytoplasmic and nuclear extracts (10 μg protein/lane) of 72-hour treated TXL2 D. or US7 E. cells using 0, 1 or 2 μM BMS345541. All cells were grown with irradiated OP9 stromal cells. proliferation. We here show that bone marrow fibroblasts but not pre-B ALL cells synthesize Galectin-3. Galectin-3 is expressed on the surface of the fibroblasts and is also secreted by them. ALL cells are known to form multiple contacts with such stromal cells and their secreted extracellular matrix, which could be strengthened by extracellular Galectin-3 lattice-promoting/crosslinking activities. (1) Soluble Galectin-3 binds to glycoproteins on the surface of pre-B ALL cells and may clusters cargo into endocytic pits that could be internalized as clathrin-independent carriers (CLIC) [37] . Cargo for Galectin-3 in pre-B ALL cells has not been determined but could include β1 integrin, CD44 and CD45 [37, 40] . (2) We show here that stromal cell-produced exosomes carrying Galectin-3, Galectin-1, and Galectin-3 binding protein form a second route of transport. Exosomes may be concentrated in fibroblastic synapses that could include the pre-B receptor and integrins that have been found in other studies [32] . Our data show that soluble Galectin-3 is spontaneously internalized by pre-B ALL cells, and persists for at least 24 hours in the cytoplasm and nucleus. Furthermore, transport to the nucleus is rapid and occurs within 1 hour. We found that exposure to soluble Galectin-3 activates NFκB and induces increased Galectin-3 mRNA transcription. Since experiments with BMS345541 show that inhibition of the canonical NFκB pathway even in the presence of stromal support is cytostatic and cytotoxic for pre-B ALL cells, stromal Galectin-3 may protect ALL cells through auto-induction of Galectin-3 mRNA and tonic NFκB pathway activation.
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